Genetics, Vol. 167, 859-866, June 2004, Copyright © 2004
doi:10.1534/genetics.103.024521

A Potent Modifier of Liver Cancer Risk on Distal Mouse Chromosome 1

Linkage Analysis and Characterization of Congenic Lines

McArdle Laboratory for Cancer Research, University of Wisconsin Medical School, Madison, Wisconsin 53706

5 Corresponding author: McArdle Laboratory for Cancer Research, 1400 University Ave., University of Wisconsin Medical School, Madison, WI 53706.
E-mail: drinkwater{at}oncology.wisc.edu

The C3H/HeJ (C3H) and CBA/J (CBA) mouse strains are classical mouse models of cancer susceptibility, exhibiting high risks for both spontaneous and chemically induced liver cancer. By analysis of backcrosses and intercrosses between C3H or CBA and resistant B6 mice, we have mapped a potent modifier of hepatocellular carcinoma development to distal chromosome 1, linked to the marker D1Mit33 with combined LODW scores of ~5.9 (C3H) and 6.5 (CBA). We previously identified this region as one of two that modify susceptibility in the more distantly related C57BR/cdJ (BR) strain. Congenic B6.C3H(D1Mit5-D1Mit17) and B6.BR(D1Mit5-D1Mit17) mice developed significantly more liver tumors than B6 mice did (6- to 13-fold, P < 10–11, in males; 3- to 4-fold, P < 10–3, in females). Thus, distal chromosome 1 carries one or more genes that are sufficient to confer susceptibility to liver cancer.




This article has been cited by other articles:


Home page
Exp. Biol. Med.Home page
F. Feo, M. Frau, M. L. Tomasi, S. Brozzetti, and R. M. Pascale
Genetic and Epigenetic Control of Molecular Alterations in Hepatocellular Carcinoma
Experimental Biology and Medicine, July 1, 2009; 234(7): 726 - 736.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. E.-M. Peychal, A. Bilger, H. C. Pitot, and N. R. Drinkwater
Predominant modifier of extreme liver cancer susceptibility in C57BR/cdJ female mice localized to 6 Mb on chromosome 17
Carcinogenesis, May 1, 2009; 30(5): 879 - 885.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Wang, D. Teske, A. Tess, R. Kohlhepp, Y. Choi, C. Kendziorski, and A. R. Moser
Identification of Novel Modifier Loci of ApcMin Affecting Mammary Tumor Development
Cancer Res., December 1, 2007; 67(23): 11226 - 11233.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. R. De Miglio, P. Virdis, D. F. Calvisi, M. Frau, M. R. Muroni, M. M. Simile, L. Daino, G. M. Careddu, E. Sanna-Passino, R. M. Pascale, et al.
Mapping a Sex Hormone-Sensitive Gene Determining Female Resistance to Liver Carcinogenesis in a Congenic F344.BN-Hcs4 Rat
Cancer Res., November 1, 2006; 66(21): 10384 - 10390.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
T. L. Thomae, E. A. Stevens, A. L. Liss, N. R. Drinkwater, and C. A. Bradfield
The Teratogenic Sensitivity to 2,3,7,8-Tetrachlorodibenzo-p-dioxin Is Modified by a Locus on Mouse Chromosome 3
Mol. Pharmacol., March 1, 2006; 69(3): 770 - 775.
[Abstract] [Full Text] [PDF]